| Application no. and date | 20753562.6 (espacenet) (Federated) (European Patent Register), 20200716 | | Patent/reg. no. and date | DK/EP 3999180, 20240508 | | Publication date | 20220525 | | Priority no. and date | US 201962875350 P, 20190717 | | EP pub. no. and date |
EP 3999180 20220525 | | Effective date | | | Applicant/owner | Cytokinetics, Inc., 350 Oyster Point Blvd
South San Francisco CA 94080, US | | Applicant ref. no. | V475248DK00 | | Inventor | TOM, Norma, 3913 Christian Drive
Belmont, California 94002, US,
PFEIFFER, Matthew, 567 E. 6th Avenue
Salt Lake City, Utah 84103, US,
ANDERSEN, Denise, PO Box 371608
Montara, California 94037, US,
GAO, Qi, 5 Hoagland Place
Franklin Park, New Jersey 08823, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61P 9/04 (2006.01) , C07D 413/12 (2006.01) | | Title | Polymorfer af (R)-N-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1 -methyl-1H-pyrazol-4-carboxamid | | Int. application no. | US2020042387 | | Int. publication no. | WO2021011807 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
